Related Experiment Video

Updated: Apr 12, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

3.4K

How do K-RAS-activated cells evade cellular defense mechanisms?

Y-S Lee1, S-C Bae1

  • 1Department of Biochemistry, School of Medicine, and Institute for Tumor Research, Chungbuk National University, Cheongju, South Korea.

Oncogene
|May 12, 2015
PubMed

Insights

K-RAS mutations drive lung cancer by disrupting cell cycle control. Cells with these mutations survive only when cellular defense mechanisms, like the ARF-p53 pathway, are already compromised.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Lung adenocarcinomas arise from accumulated genetic and epigenetic changes.
  • K-RAS mutations are critical early events in lung carcinogenesis.
  • Aberrant signaling pathways can lead to uncontrolled cell growth if cellular defenses fail.

Purpose of the Study:

  • To investigate how K-RAS-activated cells evade cellular defense mechanisms.
  • To identify molecular events enabling early dysplastic lesions to resist oncogene activation.
  • To explore the link between differentiation regulators and oncogene surveillance.

Main Methods:

  • Review of existing evidence on K-RAS-induced lung tumorigenesis.
  • Analysis of the role of lineage-determining transcriptional regulators.
  • Examination of the RUNX3 gene's function in lung cancer development and the ARF-p53 pathway.

Main Results:

  • K-RAS-activated cells do not inherently evade defense mechanisms.
  • Cellular defense mechanisms, including the ARF-p53 pathway, are abrogated in cells selected for K-RAS mutations.
  • RUNX3 inactivation in mouse lung models leads to adenoma and abrogates the ARF-p53 pathway, suggesting cross-talk between differentiation and surveillance.

Conclusions:

  • K-RAS-driven lung tumorigenesis is facilitated by the pre-existing abrogation of cellular defense mechanisms.
  • RUNX3 plays a unique role, linking cell differentiation status to oncogene surveillance.
  • The selection of K-RAS-mutated cells depends on a compromised cellular defense system.

More Related Videos

The Drosophila Imaginal Disc Tumor Model: Visualization and Quantification of Gene Expression and Tumor Invasiveness Using Genetic Mosaics10:31

The Drosophila Imaginal Disc Tumor Model: Visualization and Quantification of Gene Expression and Tumor Invasiveness Using Genetic Mosaics

Published on: October 6, 2016

12.0K
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.6K

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.6K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
10.7K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K